Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/28/23 06:15 | 9/15/23 | OKYO | Health | BioPrd | Biological Products, (No Diag | Brancaccio John P | D | P | 25 | 1.50 | 0 | 17 | New | 17 | D | ||||||||||||||||
5/20/22 10:35 | 5/19/22 | OKYO | Health | BioPrd | Biological Products, (No Diag | Cerrone Gabriele M | Y7 | DO | Exec CB | P | 441 | 0.0760 | 0 | 5,800 | 1 | 548,981 | I | ||||||||||||||
5/19/22 11:14 | 5/19/22 | OKYO | Health | BioPrd | Biological Products, (No Diag | Jacob Gary S | Y7 | DO | CEO | P | 50 | 4.00 | 0 | 13 | New | 13 | D | ||||||||||||||
5/19/22 11:14 | 5/19/22 | OKYO | Health | BioPrd | Biological Products, (No Diag | Cerrone Gabriele M | Y7 | DOT | Non-Exec | P | 150 | 4.00 | 0 | 38 | 150 | 63 | I | ||||||||||||||
5/18/22 13:38 | 5/17/22 | OKYO | Health | BioPrd | Biological Products, (No Diag | Cerrone Gabriele M | Y7 | DOT | Non-Exec | P.a | 97 | 3.87 | 0 | 25 | New | 25 | I | ||||||||||||||
5/18/22 11:37 | 5/17/22 | OKYO | Health | BioPrd | Biological Products, (No Diag | Cerrone Gabriele M | Y7 | DOT | Non-Exec | P | 97 | 0.0595 | 0 | 1,625 | 0 | 544,806 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |